Ariel L. Shiloh

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4f28f3b0-3caf-11ec-80f7-67047826a941.jpg

First Name

Ariel

Last Name

Shiloh

NPI

1346561891

Faculty ID

12325

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNormal" style="background: white;">Dr. Shiloh is the Director of the Critical Care Medicine Consult Service and Professor of Medicine at Montefiore Medical Center/Albert Einstein College of Medicine. As a clinician-educator he serves as the director of critical care ultrasonography.&nbsp;&nbsp;</p>
<p class="MsoNormal" style="background: white;">After receiving his medical degree from the Medical School for International Health at Ben Gurion University of the Negev in 2005, he completed both his Internal Medicine residency and Critical Care Medicine fellowship at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Shiloh joined the Montefiore/Einstein Critical Care faculty in 2010.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;Dr. Shiloh is board-certified in:&nbsp;</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Internal Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Critical Care Medicine</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Neurocritical Care</p>
<p class="MsoNormal" style="background: white;">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Hospice and Palliative Medicine</p>
<p class="MsoNormal" style="background: white;">As an active member of CHEST, Dr. Shiloh serves as faculty leader and co-chair for the Critical Care Ultrasound: Integration Into Clinical Practice course.&nbsp; He is an active contributor to CHEST&rsquo;s &ldquo;Better with Ultrasound&rdquo; and &ldquo;Ultrasound Corner&rdquo; series and a recipient of the &ldquo;Distinguished Chest Educator&rdquo; award.&nbsp;<span style="color: #262626; font-family: Verdana;">Award recipients represent the top 4% of CHEST&rsquo;s international faculty and are recognized for their achievements and long-term contributions to the design and delivery of CHEST education.</span></p>
<p class="MsoNormal" style="background: white;">Dr. Shiloh has authored over 50 original articles, co-edited the &ldquo;The 5-Minute ICU Consult&rdquo; published by Lippincott Williams &amp; Wilkins, and has authored over 15 book chapters. His areas of interest and research include use of point of care ultrasonography, early identification of critical illness, and critical care education and simulation training.&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>
<p class="MsoNormal" style="background: white;">&nbsp;</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Early Detection and Treatment of Critical Illness, Point Of Care Ultrasonography For The Evaluation Of Critical Illness, Advanced Airway Management

Research Focus

Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation.

Elsevier Profile

Selected Publications

<p>1: Shah TE, Vij R, Kim YH, Shiloh AL. Sudden Unilateral Vision Loss in a Patient</p>
<p>Who Received Intravenous Thrombolytic Therapy. Chest. 2021 Dec;160(6):e669-e672.</p>
<p>doi: 10.1016/j.chest.2021.03.074. PMID: 34872684.</p>
<p>&nbsp;</p>
<p>2: Nauka PC, Chen JT, Shiloh AL, Eisen LA, Fein DG. Practice, Outcomes, and</p>
<p>Complications of Emergent Endotracheal Intubation by Critical Care Practitioners</p>
<p>During the COVID-19 Pandemic. Chest. 2021 Dec;160(6):2112-2122. doi:</p>
<p>10.1016/j.chest.2021.06.008. Epub 2021 Jun 15. PMID: 34139207; PMCID:</p>
<p>PMC8204844.</p>
<p>&nbsp;</p>
<p>3: Savel RH, Shiloh AL, Kupfer Y, Hope AA. The Complex Issue of Race and</p>
<p>Coronavirus Disease 2019 in the ICU. Crit Care Med. 2021 Mar 1;49(3):532-535.</p>
<p>doi: 10.1097/CCM.0000000000004766. PMID: 33616353.</p>
<p>&nbsp;</p>
<p>4: Jabbour E, Malik D, Shiloh AL. Sudden Cardiopulmonary Collapse in a Patient</p>
<p>With Coronavirus Disease 2019. Chest. 2021 Feb;159(2):e127-e129. doi:</p>
<p>10.1016/j.chest.2020.05.618. PMID: 33563455; PMCID: PMC7859694.</p>
<p>&nbsp;</p>
<p>5: Savel RH, Kupfer Y, Shiloh AL. Steady As She Goes: Practicing Evidence-Based</p>
<p>Critical Care When the Evidence Is Limited. Chest. 2021 Jan;159(1):7-8. doi:</p>
<p>10.1016/j.chest.2020.09.245. PMID: 33422231; PMCID: PMC7787062.</p>
<p>&nbsp;</p>
<p>6: Tirumandas M, Gendlina I, Figueredo J, Shiloh A, Trachuk P, Jain R, Corpuz M,</p>
<p>Spund B, Maity A, Shmunko D, Garcia M, Barthelemy D, Weston G, Madaline T.</p>
<p>Analysis of catheter utilization, central line associated bloodstream</p>
<p>infections, and costs associated with an inpatient critical care-driven vascular</p>
<p>access model. Am J Infect Control. 2021 May;49(5):582-585. doi:</p>
<p>10.1016/j.ajic.2020.10.006. Epub 2020 Oct 17. PMID: 33080360.</p>
<p>&nbsp;</p>
<p>7: Fein DG, Zhao D, Swartz K, Nauka P, Andrea L, Aboodi M, Shiloh AL, Eisen LA.</p>
<p>The Impact of Nighttime on First Pass Success During the Emergent Endotracheal</p>
<p>Intubation of Critically Ill Patients. J Intensive Care Med. 2021</p>
<p>Dec;36(12):1498-1506. doi: 10.1177/0885066620965166. Epub 2020 Oct 15. PMID:</p>
<p>33054483.</p>
<p>&nbsp;</p>
<p>8: Kapoor S, Chand S, Dieiev V, Fazzari M, Tanner T, Lewandowski DC, Nalla A,</p>
<p>Abdulfattah O, Aboodi MS, Shiloh AL, Gong MN. Thromboembolic Events and Role of</p>
<p>Point of Care Ultrasound in Hospitalized Covid-19 Patients Needing Intensive</p>
<p>Care Unit Admission. J Intensive Care Med. 2021 Dec;36(12):1483-1490. doi:</p>
<p>10.1177/0885066620964392. Epub 2020 Oct 6. PMID: 33021131; PMCID: PMC7539230.</p>
<p>&nbsp;</p>
<p>9: Emami N, Tanner T, Ogundipe F, Hawn VS, Rubin R, Skae CC, Shiloh AL, Keene</p>
<p>AB. Drape to prevent disease transmission during endotracheal intubation. Am J</p>
<p>Infect Control. 2021 Mar;49(3):387-388. doi: 10.1016/j.ajic.2020.06.212. Epub</p>
<p>2020 Jul 3. PMID: 32628982; PMCID: PMC7333628.</p>
<p>&nbsp;</p>
<p>10: Millington SJ, Colvin MO, Shiloh AL, Koenig S. How I Do It: Ultrasound-</p>
<p>Guided Internal Jugular and Femoral Central Venous Catheter Insertion. Chest.</p>
<p>2020 Dec;158(6):2425-2430. doi: 10.1016/j.chest.2020.06.026. Epub 2020 Jun 26.</p>
<p>PMID: 32599065.</p>
<p>&nbsp;</p>
<p>11: Savel RH, Shiloh AL, Saunders PC, Kupfer Y. Mechanical Ventilation During</p>
<p>the Coronavirus Disease 2019 Pandemic: Combating the Tsunami of Misinformation</p>
<p>From Mainstream and Social Media. Crit Care Med. 2020 Sep;48(9):1398-1400. doi:</p>
<p>10.1097/CCM.0000000000004462. PMID: 32496274; PMCID: PMC7302097.</p>
<p>&nbsp;</p>
<p>12: Shiloh AL, McPhee C, Eisen L, Koenig S, Millington SJ. Better With</p>
<p>Ultrasound: Detection of DVT. Chest. 2020 Sep;158(3):1122-1127. doi:</p>
<p>10.1016/j.chest.2020.01.038. Epub 2020 Feb 20. PMID: 32087215.</p>
<p>&nbsp;</p>
<p>13: Islam M, Levitus M, Eisen L, Shiloh AL, Fein D. Lung Ultrasound for the</p>
<p>Diagnosis and Management of Acute Respiratory Failure. Lung. 2020</p>
<p>Feb;198(1):1-11. doi: 10.1007/s00408-019-00309-1. Epub 2020 Jan 1. PMID:</p>
<p>31894411.</p>
<p>&nbsp;</p>
<p>14: Fein DG, Mastroianni F, Murphy CG, Aboodi M, Malik R, Emami N, Abramowitz M,</p>
<p>Shiloh AL, Eisen L. Impact of a Critical Care Specialist Intervention on First</p>
<p>Pass Success for Emergency Airway Management Outside the ICU. J Intensive Care</p>
<p>Med. 2021 Jan;36(1):80-88. doi: 10.1177/0885066619886816. Epub 2019 Nov 10.</p>
<p>PMID: 31707906.</p>
<p>&nbsp;</p>
<p>15: Millington SJ, Hendin A, Shiloh AL, Koenig S. Better With Ultrasound:</p>
<p>Peripheral Intravenous Catheter Insertion. Chest. 2020 Feb;157(2):369-375. doi:</p>
<p>10.1016/j.chest.2019.04.139. Epub 2019 Oct 22. PMID: 31654617.</p>
<p>&nbsp;</p>
<p>16: Wang A, Hendin A, Millington SJ, Koenig S, Eisen LA, Shiloh AL. Better With</p>
<p>Ultrasound: Arterial Line Placement. Chest. 2020 Mar;157(3):574-579. doi:</p>
<p>10.1016/j.chest.2019.08.2209. Epub 2019 Oct 18. PMID: 31634448.</p>
<p>&nbsp;</p>
<p>17: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Getting It Right for Our Patients:</p>
<p>The Importance of Collaborative Leadership in the ICU. Crit Care Med. 2019</p>
<p>Sep;47(9):1279-1281. doi: 10.1097/CCM.0000000000003880. PMID: 31415316.</p>
<p>&nbsp;</p>
<p>18: Islam M, Bangar M, Shiloh AL. A Woman in Her 70s on Anticoagulation With</p>
<p>Sudden Shock. Chest. 2019 May;155(5):e123-e126. doi:</p>
<p>10.1016/j.chest.2018.10.052. PMID: 31060707.</p>
<p>&nbsp;</p>
<p>19: Patrawalla P, Narasimhan M, Eisen L, Shiloh AL, Koenig S, Mayo P. A</p>
<p>Regional, Cost-Effective, Collaborative Model for Critical Care Fellows'</p>
<p>Ultrasonography Education. J Intensive Care Med. 2020 Dec;35(12):1447-1452. doi:</p>
<p>10.1177/0885066619828951. Epub 2019 Feb 12. PMID: 30755062.</p>
<p>&nbsp;</p>
<p>20: Shiloh AL. Smooth Transitions in Critical Care. J Emerg Trauma Shock. 2018</p>
<p>Jul-Sep;11(3):154-155. doi: 10.4103/JETS.JETS_44_17. PMID: 30429619; PMCID:</p>
<p>PMC6182967.</p>
<p>&nbsp;</p>
<p>21: Savel RH, Shiloh AL. Are We Really Doing More With Less: The Value of Half-</p>
<p>Dose Alteplase in Pulmonary Embolism Therapy. Crit Care Med. 2018</p>
<p>Oct;46(10):1696-1697. doi: 10.1097/CCM.0000000000003303. PMID: 30216306.</p>
<p>&nbsp;</p>
<p>22: Savel RH, Borgia D, Shiloh AL. A Path to High-Quality Care: Implementing</p>
<p>Flexible Visitation While Avoiding Staff Burnout. Crit Care Med. 2018</p>
<p>Jul;46(7):1203-1204. doi: 10.1097/CCM.0000000000003167. PMID: 29912108.</p>
<p>&nbsp;</p>
<p>23: Ferenchick HR, Chua AT, Carlese AJ, Shiloh AL. A Woman With Recent Stroke</p>
<p>Presenting With Respiratory Failure and Shock. Chest. 2018 May;153(5):e101-e103.</p>
<p>doi: 10.1016/j.chest.2017.11.048. PMID: 29731049.</p>
<p>&nbsp;</p>
<p>24: Savel RH, Shiloh AL, Simon RJ, Kupfer Y. Using Big Data to See the Big</p>
<p>Picture in Sepsis. Crit Care Med. 2018 Apr;46(4):640-641. doi:</p>
<p>10.1097/CCM.0000000000002976. PMID: 29538113.</p>
<p>&nbsp;</p>
<p>25: Kumarasamy N, Tishbi N, Mukundan S, Shiloh A, Levsky JM, Haramati LB.</p>
<p>Cardiothoracic MRI in the ICU: A 10-Year Experience. Acad Radiol. 2018</p>
<p>Mar;25(3):359-364. doi: 10.1016/j.acra.2017.09.017. Epub 2018 Feb 6. PMID:</p>
<p>29426683.</p>
<p>&nbsp;</p>
<p>26: Lishmanov A, Bellamkonda TT, Shiloh AL. A Woman in Her 20s With</p>
<p>Cardiopulmonary Failure. Chest. 2017 Jun;151(6):e123-e125. doi:</p>
<p>10.1016/j.chest.2017.01.040. PMID: 28599944.</p>
<p>&nbsp;</p>
<p>27: Shiloh AL, Sobolev M, Di Biase L, Slovut DP. A call for safety during</p>
<p>electrophysiological procedures: US in, why not US out? Authors' reply.</p>
<p>Europace. 2017 Dec 1;19(12):2048-2049. doi: 10.1093/europace/eux007. PMID:</p>
<p>28340047.</p>
<p>&nbsp;</p>
<p>28: Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation</p>
<p>of the femoral vein in electrophysiological procedures: a systematic review and</p>
<p>meta-analysis. Europace. 2017 May 1;19(5):850-855. doi: 10.1093/europace/euw113.</p>
<p>PMID: 27207813.</p>
<p>&nbsp;</p>
<p>29: Shiloh AL, Lominadze G, Gong MN, Savel RH. Early Warning/Track-and-Trigger</p>
<p>Systems to Detect Deterioration and Improve Outcomes in Hospitalized Patients.</p>
<p>Semin Respir Crit Care Med. 2016 Feb;37(1):88-95. doi: 10.1055/s-0035-1570352.</p>
<p>Epub 2016 Jan 28. PMID: 26820276.</p>
<p>&nbsp;</p>
<p>30: Patrawalla P, Eisen LA, Shiloh A, Shah BJ, Savenkov O, Wise W, Evans L, Mayo</p>
<p>P, Szyld D. Development and Validation of an Assessment Tool for Competency in</p>
<p>Critical Care Ultrasound. J Grad Med Educ. 2015 Dec;7(4):567-73. doi:</p>
<p>10.4300/JGME-D-14-00613.1. PMID: 26692968; PMCID: PMC4675413.</p>
<p>&nbsp;</p>
<p>31: Hena KM, Eisen LA, Shiloh AL. A Man in His 60s With Renal Failure and Shock</p>
<p>Refractory to Vasopressors. Chest. 2015 Dec;148(6):e171-e174. doi:</p>
<p>10.1378/chest.15-0160. PMID: 26621295.</p>
<p>&nbsp;</p>
<p>32: Bernier-Jean A, Albert M, Shiloh AL, Eisen LA, Williamson D, Beaulieu Y. The</p>
<p>Diagnostic and Therapeutic Impact of Point-of-Care Ultrasonography in the</p>
<p>Intensive Care Unit. J Intensive Care Med. 2017 Mar;32(3):197-203. doi:</p>
<p>10.1177/0885066615606682. Epub 2016 Jul 9. PMID: 26423745.</p>
<p>&nbsp;</p>
<p>33: Shiloh AL, Adrish M. A Man in His 60s With Cirrhosis, Encephalopathy, and</p>
<p>Shock. Chest. 2015 Jul;148(1):e5-e7. doi: 10.1378/chest.14-2201. PMID: 26149567.</p>
<p>&nbsp;</p>
<p>34: Sobolev M, Slovut DP, Lee Chang A, Shiloh AL, Eisen LA. Ultrasound-Guided</p>
<p>Catheterization of the Femoral Artery: A Systematic Review and Meta-Analysis of</p>
<p>Randomized Controlled Trials. J Invasive Cardiol. 2015 Jul;27(7):318-23. PMID:</p>
<p>26136279.</p>
<p>&nbsp;</p>
<p>35: Adrish M, Shiloh AL. A woman in her 50s with recent coronary artery bypass</p>
<p>grafting presenting with right-sided chest pain. Chest. 2015</p>
<p>May;147(5):e171-e174. doi: 10.1378/chest.14-0457. PMID: 25940259.</p>
<p>&nbsp;</p>
<p>36: Shiloh AL, Ari Eisen L, Savel RH. The unplanned intensive care unit</p>
<p>admission. J Crit Care. 2015 Apr;30(2):419-20. doi: 10.1016/j.jcrc.2014.12.010.</p>
<p>Epub 2014 Dec 24. PMID: 25579373.</p>
<p>&nbsp;</p>
<p>37: Eisen LA, Savel RH, Shiloh AL. Video laryngoscopy in the intensive care</p>
<p>unit. A clearer view? Ann Am Thorac Soc. 2014 Oct;11(8):1254-5. doi:</p>
<p>10.1513/AnnalsATS.201408-386ED. PMID: 25343195.</p>
<p>&nbsp;</p>
<p>38: Chung M, Shiloh AL, Carlese A. Monitoring of the adult patient on</p>
<p>venoarterial extracorporeal membrane oxygenation. ScientificWorldJournal.</p>
<p>2014;2014:393258. doi: 10.1155/2014/393258. Epub 2014 Apr 3. PMID: 24977195;</p>
<p>PMCID: PMC3998007.</p>
<p>&nbsp;</p>
<p>39: Karakitsos D, El Barbary M, Gillman LM, Papalois A, Shiloh A. Critical care</p>
<p>and perioperative monitoring. ScientificWorldJournal. 2014;2014:737628. doi:</p>
<p>10.1155/2014/737628. Epub 2014 May 4. PMID: 24892082; PMCID: PMC4032705.</p>
<p>&nbsp;</p>
<p>40: Tischenkel BR, Gong MN, Shiloh AL, Pittignano VC, Keschner YG, Glueck JA,</p>
<p>Cohen HW, Eisen LA. Daytime Versus Nighttime Extubations: A Comparison of</p>
<p>Reintubation, Length of Stay, and Mortality. J Intensive Care Med. 2016</p>
<p>Feb;31(2):118-26. doi: 10.1177/0885066614531392. Epub 2014 Apr 24. PMID:</p>
<p>24763118.</p>
<p>&nbsp;</p>
<p>41: Shiloh AL, Kazzi MG, Mathew R, Eisen LA, Carlese AJ. A man in his 40s with a</p>
<p>history of hypertension and alcohol dependency presenting to the ED with</p>
<p>respiratory distress: septic shock in the setting of ARDS. Chest. 2014</p>
<p>Feb;145(2):e3-e6. doi: 10.1378/chest.13-2089. PMID: 24493554.</p>
<p>&nbsp;</p>
<p>42: Shiloh AL, Sobolev M, Eisen LA. A woman in her 30s in respiratory distress</p>
<p>with a history of gestational diabetes and hypertension. Chest. 2014</p>
<p>Jan;145(1):e1-e2. doi: 10.1378/chest.13-1850. PMID: 24394849.</p>
<p>&nbsp;</p>
<p>43: Lahiri S, Boro AD, Shiloh AL, Milstein MJ, Savel RH. Periodic Epileptiform</p>
<p>Discharges Clarified for the Nonneurologist Intensivist: Clinical Implications</p>
<p>and Current Management. J Intensive Care Med. 2015 Oct;30(7):385-91. doi:</p>
<p>10.1177/0885066613513411. Epub 2013 Dec 9. PMID: 24323590.</p>
<p>&nbsp;</p>
<p>44: Eisen LA, Janowski W, Shiloh AL. Ultrasound diagnosis of shock in a woman</p>
<p>with metastatic renal cell carcinoma. Chest. 2013 Sep;144(3):e1-e3. doi:</p>
<p>10.1378/chest.13-0964. PMID: 24008972.</p>
<p>&nbsp;</p>
<p>45: Savel RH, Shiloh AL, Eisen LA. Tackling the tough questions: what was this</p>
<p>patient like before they were critically ill? Crit Care Med. 2013</p>
<p>Jan;41(1):327-8. doi: 10.1097/CCM.0b013e318267a8ad. PMID: 23269133.</p>
<p>&nbsp;</p>
<p>46: Shiloh AL, Eisen LA, Yee M, Langner JB, LeDonne J, Karakitsos D. Ultrasound-</p>
<p>guided subclavian and axillary vein cannulation via an infraclavicular approach:</p>
<p>In the tradition of Robert Aubaniac. Crit Care Med. 2012 Oct;40(10):2922-3. doi:</p>
<p>10.1097/CCM.0b013e31825cea64. PMID: 22986669.</p>
<p>&nbsp;</p>
<p>47: Keene AB, Shiloh AL, Dudaie R, Eisen LA, Savel RH. Online testing from</p>
<p>Google Docs&trade; to enhance teaching of core topics in critical care: a pilot study.</p>
<p>Med Teach. 2012;34(12):1075-7. doi: 10.3109/0142159X.2012.716553. Epub 2012 Aug</p>
<p>30. PMID: 22931149.</p>
<p>&nbsp;</p>
<p>48: Stefanidis K, Pentilas N, Dimopoulos S, Nanas S, Savel RH, Shiloh AL,</p>
<p>Poularas J, Slama M, Karakitsos D. Echogenic Technology Improves Cannula</p>
<p>Visibility during Ultrasound-Guided Internal Jugular Vein Catheterization via a</p>
<p>Transverse Approach. Crit Care Res Pract. 2012;2012:306182. doi:</p>
<p>10.1155/2012/306182. Epub 2012 May 10. PMID: 22649715; PMCID: PMC3357505.</p>
<p>&nbsp;</p>
<p>49: Stefanidis K, Fragou M, Pentilas N, Kouraklis G, Nanas S, Savel RH, Shiloh</p>
<p>AL, Slama M, Karakitsos D. Optimization of Cannula Visibility during Ultrasound-</p>
<p>Guided Subclavian Vein Catheterization, via a Longitudinal Approach, by</p>
<p>Implementing Echogenic Technology. Crit Care Res Pract. 2012;2012:617149. doi:</p>
<p>10.1155/2012/617149. Epub 2012 Apr 23. PMID: 22593825; PMCID: PMC3347863.</p>
<p>&nbsp;</p>
<p>50: Savel RH, Shiloh AL, Eisen LA. Educational impact of continuous chest</p>
<p>compression cardiopulmonary resuscitation: the confidence to "pay it forward"*.</p>
<p>Crit Care Med. 2012 Mar;40(3):992-3. doi: 10.1097/CCM.0b013e31823878b1. PMID:</p>
<p>22343848.</p>
<p>&nbsp;</p>
<p>51: Shiloh AL, Eisen LA, Savel RH. Goal-directed ultrasonography in the</p>
<p>intensive care unit: no more excuses! Crit Care Med. 2011 Apr;39(4):879-80. doi:</p>
<p>10.1097/CCM.0b013e318208e393. PMID: 21613832.</p>
<p>&nbsp;</p>
<p>52: Rosenberg JB, Shiloh AL, Savel RH, Eisen LA. Non-invasive methods of</p>
<p>estimating intracranial pressure. Neurocrit Care. 2011 Dec;15(3):599-608. doi:</p>
<p>10.1007/s12028-011-9545-4. PMID: 21519957.</p>
<p>&nbsp;</p>
<p>53: Kory PD, Pellecchia CM, Shiloh AL, Mayo PH, DiBello C, Koenig S. Accuracy of</p>
<p>ultrasonography performed by critical care physicians for the diagnosis of DVT.</p>
<p>Chest. 2011 Mar;139(3):538-542. doi: 10.1378/chest.10-1479. Epub 2010 Oct 28.</p>
<p>PMID: 21030490.</p>
<p>&nbsp;</p>
<p>54: Shiloh AL, Savel RH, Paulin LM, Eisen LA. Ultrasound-guided catheterization</p>
<p>of the radial artery: a systematic review and meta-analysis of randomized</p>
<p>controlled trials. Chest. 2011 Mar;139(3):524-529. doi: 10.1378/chest.10-0919.</p>
<p>Epub 2010 Aug 19. PMID: 20724734.</p>
<p>&nbsp;</p>
<p>55: Shiloh AL, Eisen LA, Savel RH. Selective decontamination of the digestive</p>
<p>tract: what outcomes matter? Crit Care Med. 2010 May;38(5):1386-7. doi:</p>
<p>10.1097/CCM.0b013e3181da47d1. PMID: 20404637.</p>
<p>&nbsp;</p>
<p>56: Shiloh AL, Eisen LA. Ultrasound-guided arterial catheterization: a narrative</p>
<p>review. Intensive Care Med. 2010 Feb;36(2):214-21. doi:</p>
<p>10.1007/s00134-009-1699-6. Epub 2009 Oct 31. PMID: 19882140.</p>
<p>&nbsp;</p>
<p>57: Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W. Deubiquitination of</p>
<p>p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002 Apr</p>
<p>11;416(6881):648-53. doi: 10.1038/nature737. Epub 2002 Mar 31. PMID: 11923872.</p>

EMR ID

4723

Biography

<p>Ariel L Shiloh, MD, is Director, Critical Care Consult Services, Professor, Medicine and Associate Professor, Neurology at Montefiore Einstein. Dr. Shiloh&rsquo;s clinical interests include the early detection and treatment of critical illness, point-of-care ultrasonography for the evaluation of critical illness and advanced airway management.</p><p>After earning his Bachelor of Arts from Yeshiva University, Dr. Shiloh attended the Medical School for International Health at Ben Gurion University, Be&rsquo;er Sheva, Israel, earning his Doctor of Medicine in 2005. He came to Montefiore for his postdoctoral training, completing his internship and residency in internal medicine in 2008, followed by his fellowship in critical care medicine in 2010.</p><p>Dr. Shiloh's research includes the clinical use of point-of-care ultrasonography in critical illness, improvement of airway management, and cardiopulmonary resuscitation. He has shared his work through peer-reviewed journals, invited presentations, books, abstracts and poster presentations at national conferences. He has also been a reviewer for several journals including <em>Chest</em>, the <em>American Journal of Critical Care</em> and the <em>European Journal of Anesthesiology</em>.</p><p>Dr. Shiloh is board certified in Internal Medicine, Critical Care Medicine and Neurocritical Care and Hospice &amp; Palliative Medicine. He is a Fellow of the American College of Chest Physicians and a member of the Society of Critical Care Medicine. Dr. Shiloh has been recognized by the American College of Chest Physicians as a Distinguished CHEST Educator, among the top 5% of CHEST&rsquo;s international faculty recognized for long-term contributions to the design and delivery of CHEST education</p>

Is Open Scheduling

Off

Chirag D. Shah

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shah_Chirag_MD_420x504.jpg

First Name

Chirag

Last Name

Shah

NPI

1164629770

Faculty ID

15234

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5732

Visit Type ID

2542

Is Open Scheduling

On

Scott J. Schafler

https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg

First Name

Scott

Last Name

Schafler

NPI

1417219585

Faculty ID

16440

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

55639

Is Open Scheduling

Off

Ali Sadoughi

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0896c190-56c0-11ec-a12b-63debfbf42ce.jpg

First Name

Ali

Last Name

Sadoughi

NPI

1699933879

Faculty ID

14807

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Ali Sadoughi is Director of Interventional Pulmonology and Bronchoscopy. His clinical expertise is in interventional pulmonology and thoracic oncology, an evolving sub-specialty of pulmonary and critical care medicine. This field focuses on patients with benign and malignant chest diseases.</p>
<p>Dr. Sadoughi performs advanced diagnostic and therapeutic procedures for patients with lung nodules/masses, intra-thoracic lymphadenopathy, pleural diseases, and severe asthma. These include:</p>
<ul>
<li>Sampling of pulmonary lesions; both peripherally and centrally located in the lung; using endobronchial ultrasound (EBUS, both radial and linear array probes) and navigational bronchoscopy</li>
<li>Therapeutic rigid and flexible bronchoscopy on patients with major airway disorders, including tumor de-bulking, airway dilatation and stent placement</li>
<li>Diagnostic and therapeutic procedures on patients with pleural disease and effusion</li>
<li>Therapeutic interventions such as pleurodesis, tunneled pleural catheter and chest tube placement</li>
<li>Bronchial thermoplasty for severe asthma&nbsp;</li>
<li>Endobronchial valve placement for persistent air leak from the lung</li>
</ul>
<p>His other&nbsp;experience is in ultrasonography and echocardiography and their applications in pulmonary and critical care medicine.</p>
<p>Dr. Sadoughi's research interests are in evolution and application of sophisticated and modern technologies for early and minimally invasive diagnosis and treatment of different pulmonary diseases, from lung cancers, to airway disorders, pulmonary hypertension, interstitial lung disease, respiratory failure, and pleural diseases. The outcome of his research studies in pulmonary hypertension and interventional pulmonology has been published in high-ranking medical journals and presented in different national conferences.</p>
<h3>Clinical Specialties</h3>
<ul>
<li>Pulmonary Medicine
<ul>
<li>Interventional Pulmonology</li>
<li>Lung Cancer</li>
</ul>
</li>
<li>Critical Care</li>
</ul>
<h3>Board Certification</h3>
<ul>
<li>Pulmonary Disease</li>
<li>Critical Care Medicine</li>
<li>Internal Medicine</li>
</ul>
<h3>Education &amp; Training</h3>
<ul>
<li>Medical School: Shahid Beheshti University of Medical Sciences</li>
<li>Residency: Kingsbrook Jewish Medical Center</li>
<li>Fellowship: Hofstra-North Shore LIJ School of Medicine</li>
<li>Fellowship: Washington University in Saint Louis</li>
</ul>
<h3>Professional Memberships</h3>
<ul>
<li>American Association of Bronchology and Interventional Pulmonology (AABIP), Member</li>
<li>American College of Chest Physicians (ACCP), Member</li>
<li>American Thoracic Society (ATS), Member</li>
<li>International Association for the Study of Lung Cancer&nbsp;(IASLC),&nbsp;Member</li>
</ul>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sadoughi specializes in interventional pulmonology, a subspecialty of pulmonary and critical care medicine that uses endoscopy and other minimally invasive tools to diagnose and treat patients with benign and malignant chest diseases.

Elsevier Profile

Selected Publications

<ol>
<li>Bronchomediastinal Fistula From Erosion of Surgical Pledgets Into the Airway, Sadoughi A, Meyers B, Chenna P, Chest. 2015;148:838A. doi:10.1378/chest.2261266</li>
<li>Obstruction of the Trachea with Necrotic Tissue from a Pleomorphic Lung Carcinoma,&nbsp;Sadoughi A, Hyman K, Patel D, Chest. 2014;146:768A. doi:10.1378/chest.1991851.</li>
<li>Diagnosis and Safe Ablation of Endobronchial Hamartoma with Interventional Bronchoscopy,&nbsp;Sadoughi A, Folch E, Majid A. Am J Respir Crit Care Med 189;2014:A4447.</li>
<li>Macrophage migration inhibitory factor mediates hypoxia- induced pulmonary hypertension, Yinzhong Zhang, Arunabh Talwar, Donna Tsang, Annette Bruchfeld, Ali Sadoughi, Maowen Hu, Kennedy Omonuwa, Kai Fan Cheng, Yousef Al-Abed, and Edmund J. Miller, Molecular Medicine, Nov 2011, PMID: 22113497.</li>
<li>Impaired Heart Rate Recovery After Cardio Pulmonary Exercise Testing [CPET] In Patients with Pulmonary Arterial Hypertension, Arunabh Talwar MD, Ali Sadoughi&nbsp; MD,&nbsp; Purvesh&nbsp; Patel MD,&nbsp; Tara George, Donna Tsang, Nina Kohn MS; Chest. 2011;140(4_MeetingAbstracts):723A. doi:10.1378/chest.1119783</li>
<li>A 77-year-old woman with dyspnea and Reynaud phenomenon. Wang J, Sadoughi A, Dedopoulos S, Talwar A, Chest. 2011 Apr;139(4):958-6. PMID: 21467065</li>
<li>Intracranial Pressure Treatment Tailored to Transcranial Doppler-Derived Compliance and Perfusion. Kapinos G, Sadoughi A, Narayan R, oral presentation, November 2013 at the 15th International Conference on Intracranial Pressure and Brain Monitoring, Singapore.</li>
<li>Management of Increased Intracranial Pressure. Sadoughi A, Rybinnik I, Cohen R. The Open Critical Care Medicine Journal, 2013, 6, (Suppl 1: M4) 56-65.</li>
<li>Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension, Sadoughi A, Roberts K, Preston I, Lai GP, Mcollister D, Farber HW, Hill NS, Chest. 2013 Apr 4. PMID: 23558791.</li>
<li>Inflammatory Mechanisms in Pulmonary Hypertension, A Sadoughi, Y Zhang, EJ Miller, A Talwar; <em>CML (Current Medical Literature) &ndash; Pulmonary Hypertension </em>2010;1(4):93&ndash;106.</li>
<li>Computed Tomography Angiogram of the Chest as a Valuable Predicting Tool for Pulmonary Arterial Hypertension, A Sadoughi, N Patel, J Wang, N Kohn, R Shah, A Talwar; Chest. 2010;138(4_MeetingAbstracts):357A. doi:10.1378/chest.10559</li>
<li>Arterial Concentration of Macrophage Migration Inhibitory Factor (MIF) increases with exercise in patients with pulmonary Hypertension (PH), A Sadoughi, EJ Miller, A Talwar, presented at FOCIS 2011, Washington, DC.</li>
<li>Utility of Pulmonary Artery Diameter in Computed Tomography of Chest as a screening tool for Pulmonary Arterial Hypertension, A Sadoughi, T Chandak, N Kohn, R Shah, A Talwar, Presented in ATS Meeting, May 2010.</li>
<li>Relationship of Pulmonary Arterial Oxygen Saturation with Right Atrial Pressure in Pulmonary Hypertension, T Chandak, A Sadoughi, N Kohn, A Talwar, Presented in ATS Meeting, May 2010.</li>
<li>A case of Portopulmonary Hypertension, Sadoughi A, Mukherji R, Mehra S, Talwar A, The Journal of Respiratory Diseases, September, 2008.</li>
<li>Arteriotomy Closure Device Application Following Percutaneous Coronary Intervention May Prevent Bleeding Complication in Patients with Acute Myocardial Infarction, F. Ikeno, M. Ali Sadoughi, J. Lyons, F. Raissi, K. Pourdehmobed, V. Hashemi, S. Emami, H. Kaneda, A. C. Yeung, M. Rezaee, International J. of Cardiology, April 2007, 117(1), 131-132, PMID:16935367.</li>
<li>The Conversion in Application of Percutaneous Coronary Intervention Following the Introduction of Drug Eluting Stents, F. Ikeno, F. Raissi, M. Ali Sadoughi, J.K. Lyons, K. Pourdehmobed, V. Hashemi, S. Emami, H. Kanada, A.C. Yeung, M. Rezaee, International Journal of Cardiology, November 2006, 113(2), 279-280, PMID: 16318883.</li>
<li>Drug-eluting stents alter referral patterns for revascularization in patients with multivessel coronary artery disease, HMO Farouque, Fearon WF, Wu BM, Luna J, Shabari FR, Sadoughi MA, Lee DP, Yeung AC, Heart, Lung, Circulation 2005; 14 Suppl 1: S77, Australia</li>
<li>Changes in the Practice of Percutaneous Coronary Intervention Following the Introduction of Drug Eluting Stents, Raissi F., Sadoughi M.A., Hashemi V., Pourdehmobed K., Farouque O., Lyons J., Emami S., Ikeno F., Kaneda H., Yeung A.C., Rezaee M., TCT (Transcatheter Cardiovascular Therapeutics) meeting 2004, Washington DC, Poster Presentation, 09 / 2004.</li>
</ol>

EMR ID

78160

Biography

<p>Ali Sadoughi, MD, is Director, Interventional Pulmonology and Bronchoscopy and Associate Professor, Medicine at Montefiore Einstein. He specializes in interventional pulmonology, a subspecialty of pulmonary and critical care medicine that uses endoscopy and other minimally invasive tools to diagnose and treat patients with benign and malignant chest diseases.</p><p>After earning his Doctor of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran, Dr. Sadoughi completed an internal medicine residency at Kingsbrook Jewish Medical Center. Following this, he completed a pulmonary and critical care fellowship at Hofstra-North Shore LIJ School of Medicine in 2014 and an interventional pulmonary fellowship at Washington University in 2015.</p><p>Dr. Sadoughi's research interests are in developing and applying advanced technologies for early and minimally invasive diagnosis and treatment of pulmonary diseases. These include lung cancers, airway disorders, pulmonary hypertension, interstitial lung disease, respiratory failure and pleural diseases. His work has been published in journals including <em>Chest</em> and the <em>Journal of Molecular Medicine</em>, and he has made presentations at national and international medical meetings. One of his recent research studies focuses on the development of brachytherapy seeds (DaRT) using alpha radiation for the treatment of lung cancer, sponsored by Alpha Tau Ltd. In another study, he works with an international group of pulmonologists on the role of confocal laser endomicroscopy (CLE) in the diagnosis of different benign and malignant lung diseases. His work related to increased precision and accuracy of biopsy of peripheral lung nodules by intraprocedural 3D scanning in combination with ultrathin bronchoscopy has been published in the <em>Journal of Bronchology and Interventional Pulmonology</em>. Another area of Dr. Sadoughi&rsquo;s research involves the synergy of local therapies such as cryotherapy with immunotherapy in the treatment of lung cancer. He has presented this exciting topic at the American Association of Bronchology and Interventional Pulmonology (AABIP) Conference in 2022.</p><p>Dr. Sadoughi is board certified in interventional pulmonology, pulmonary disease, critical care medicine and internal medicine. He is a member of professional societies such as the American Association of Bronchology and Interventional Pulmonology, the World Association of Bronchology and Interventional Pulmonology, the American College of Chest Physicians, the American Thoracic Society and the International Association for the Study of Lung Cancer. He has contributed his research to the U.S. News, Politico New York and OncLive, and has been an editorial member and reviewer of multiple medical journals.</p>

Is Open Scheduling

On

Divya B. Reddy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/f08dec40-c946-11ed-8462-993dfb204153.jpg

First Name

Divya

Last Name

Reddy

NPI

1588828370

Faculty ID

14312

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Education:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy earned her medical degree from Padmashree Dr. D. Y. Patil Medical College, India. She completed a master's degree in clinical epidemiology from Boston University School of Public Health prior to starting her Internal Medicine Residency training at Boston University Medical Center. Her post-graduate training also included a Fellowship in Pulmonary and Critical Care Medicine from Boston University Medical Center with a particular focus on pulmonary infections and associated lung destruction.&nbsp;&nbsp;</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Research Interests:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy has been involved in several patient-oriented research projects in pulmonary infections. As an investigator in the Regional Prospective&nbsp;Observational Research in Tuberculosis (RePORT) cohort in Puducherry and Tamil Nadu, India&nbsp;her work focused on the impact of smoking and biomass fuel use on TB Disease and its treatment outcomes.&nbsp;She is&nbsp;currently developing a database of patients with non-tuberculous mycobacterial infections seen at Montefiore Medical Center in collaboration with the Division of Infectious Diseases. The goal of this project is to better characterize the natural history&nbsp;and clinical outcomes of these infections.&nbsp;&nbsp;She is also involved in the&nbsp;Women&rsquo;s Interagency HIV Study (WIHS) as the Bronx site pulmonologist and co-investigator to assess the impact of HIV on the development of chronic lung diseases.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;"><strong>Clinical Interests:</strong></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">1. Bronchiectasis &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">2. Tuberculosis</span></p>
<p class="MsoNormal" style="margin: 0in -67.5pt 0.0001pt 0in; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">3. Nontuberculous Mycobacterial (NTM) Infections &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">4. Obstructive lung diseases &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri; background-color: #fefefe;">5. COVID-19</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;">&nbsp;</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><strong><span style="font-size: 12pt; font-family: Calibri;">Board Certification:</span></strong></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 10pt; font-family: 'Times New Roman'; background-color: #fefefe;"><span style="font-size: 12pt; font-family: Calibri;">Dr. Reddy is board-certified in Internal Medicine, Pulmonary and Critical Care Medicine and is a<span class="apple-converted-space">&nbsp;</span><span style="border: 1pt none windowtext; padding: 0in;">member of numerous professional societies, including the American Thoracic Society and the Society of Critical Care Medicine.</span></span></p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Bronchiectasis, Nontuberculous Mycobacterial infections, COPD, Asthma, Interstitial Lung Disease<quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Bronchiectasis, Nontuberculous mycobacterial infections.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><strong><span style="font-family: Calibri;">Original Publications:</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria; text-align: justify; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Little F; Glucocorticoid-Resistant Asthma: More than meets the eye;&nbsp;<em>J Asthma</em>&nbsp;December 2013, Vol. 50, No. 10, Pages 1036-1044, PMID 23923995</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell MR, Welter-Frost AM, Coe A, Horsburgh CR. Discordance between Tuberculin Skin Test and Interferon Gamma Release Assay is Associated with Previous Latent Tuberculosis Infection Treatment.&nbsp;<em>Mycobact Dis</em>&nbsp;2016, 6:227. doi: 10.4172/2161-1068.1000227.</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jacob Walker, Gary Brandeis MD, Matt Russell MD, C Robert Horsburgh Jr, Natasha Hochberg;&nbsp;Latent Tuberculosis Infection Screening Practices in Long-Term Care Facilities<em>;&nbsp;J Am Geriatr Soc</em>, 2017, 65: 1145&ndash;1151. doi:10.1111/jgs.14696, PMID 28467605</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp; &nbsp; &nbsp;</span><strong style="font-family: Cambria; font-size: 12pt;"><span style="font-family: Calibri;">Divya Reddy</span></strong><span style="font-size: 12pt; font-family: Calibri;">, Yicheng Ma, Subitha Lakshminarayanan, Swaroop Sahu, Laura F. White, Ayiraveetil Reshma, Gautam Roy, Padmini Salgame, Selby Knudsen, Jerrold J. Ellner, C. Robert Horsburgh, Jr., Sonali Sarkar, Natasha S. Hochberg, Severe Undernutrition in Children Affects Tuberculin Skin Test Performance in Southern India. <em>PLoS ONE 16(7): e0250304. https://doi.org/10.1371/journal. pone.0250304, </em></span><span style="font-size: 12pt; font-family: Calibri;">PMID 34270546</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: Cambria;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: -0.5in;"><strong><span style="font-family: Calibri;">Book Chapters:</span></strong></p>
<p class="MsoNormal" style="margin: 0in -0.25in 0.0001pt 40.5pt; font-size: medium; font-family: Cambria; text-indent: 4.5pt;"><span style="font-family: Calibri;">&nbsp;</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O&rsquo;Donnell M,&nbsp;<strong>Reddy D</strong>, Saukkonen J; Antimycobacterial agents; 19^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine</em>, McGraw-Hill Professional, 2015. Volume 2. Chapter 205e, p. 1132-41</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, O&rsquo;Donnell M; Antimycobacterial agents; 20^th&nbsp;Edition of&nbsp;<em>Harrison&rsquo;s Principles of Internal Medicine,&nbsp;</em>McGraw-Hill Professional, 2018. Volume 1. Chapter 176, p. 1270-79</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Reddy D</strong>, Saukkonen J; Hepatoxicity associated with anti-tuberculosis treatment;<strong>&nbsp;</strong>3^rd&nbsp;Edition of&nbsp;<em>Textbook of</em>&nbsp;<em>Tuberculosis and Nontuberculous Mycobacterial Diseases,</em>&nbsp;Jaypee Brothers Medical Publishers, 2019. Chapter 45, p. 637-643</span></p>
<p class="MsoNormalCxSpMiddle" style="margin: 0in -0.25in 0.0001pt 27pt; text-indent: -22.5pt;"><span style="font-family: Calibri;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>Divya Reddy</strong>, Jerrold Ellner; Pathogenesis of Tuberculosis; 6^th&nbsp;Edition of&nbsp;<em>Clinical Tuberculosis</em>, CRC Press, 2020. Chapter 4, p. 51-76</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Cambria;"><span style="font-family: Calibri;">&nbsp;</span></p>

EMR ID

73329

Biography

<p>Divya Reddy, MD, MPH, is Program Director, Pulmonary and Critical Care Fellowship and Associate Professor, Medicine at Montefiore Einstein. Her clinical focus centers on bronchiectasis, nontuberculous mycobacterial infections, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.</p><p>After earning her Bachelor of Medicine, Bachelor of Surgery at Dr. D.Y. Patil Medical College in Mumbai, India in 2006, Dr. Reddy moved to the United States to continue her medical training, earning her Master of Public Health at Boston University in 2008. She remained there to complete her internal medicine internship in 2009, followed by her internal medicine residency in 2011. Dr. Reddy then completed a pulmonary and critical care fellowship at Boston University in 2014.</p><p>Building on her clinical experience, Dr. Reddy&rsquo;s research is focused on bronchiectasis and nontuberculous mycobacterial infections. She has been principal investigator and co-investigator on several funded research projects, and her work has been published in numerous peer-reviewed journals, book chapters, review articles and abstracts. She has also given national and international invited presentations, and is a reviewer for scientific journals including the <em>Journal of American Geriatric Society</em>, <em>Annals of American Thoracic Society</em> and the <em>Journal of Infectious &amp; Non-Infectious Diseases</em>, among others.</p><p>Dr. Reddy is board certified in Pulmonary Medicine and Critical Care Medicine by the American Board of Internal Medicine. She is a member of the American Thoracic Society, the American College of Chest Physicians and the Association of Pulmonary and Critical Care Medicine Program Directors. In 2014 and 2015, Dr. Reddy received the Potts Memorial Foundation Grant award.</p>

Visit Type ID

2542

Is Open Scheduling

On

David J. Prezant

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4db93d60-5bd2-11ef-9c26-99fb988c3389.jpg

First Name

David

Last Name

Prezant

NPI

1184713489

Faculty ID

2422

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. David Prezant is the Chief Medical Officer at the Office of Medical Affairs for the Fire Department of the City of New York (FDNY). Dr. Prezant directs all medical protocol development for both day-to-day operations and homeland security issues. He is also Co-Director of the FDNY World Trade Center Medical Monitoring Program and the Senior Pulmonary Consultant for FDNY.</p>

<p>Dr. Prezant is a member of the Institute of Medicine's Committee on Personal Protective Equipment in the Workplace, the National Fire Protection Association's Health and Safety Committee, and the International Association of Firefighters Redmond Medical Advisory Board. He is a Professor of Medicine at the Albert Einstein College of Medicine; Director of Albert Einstein Medical School's Pulmonary Course for medical students and the Research Director for their Unified Pulmonary Division.</p>

<p>Dr. Prezant responded on 9/11/01 to the World Trade Center and was present during the collapse and its aftermath. Since that day, he and Dr. Kelly (FDNY's Chief Medical Officer at the Bureau of Health Services) have initiated a multi-million dollar medical monitoring and treatment program for FDNY firefighters funded by FDNY, the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH).</p>

<p>Dr. Prezant is the Principal Investigator for the FDNY Data Coordinating Center for the WTC Medical Monitoring Program and is on the Steering Committee for the WTC Medical Monitoring Program. He served as a member of the EPA WTC Technical Advisory Committee, the NYC Dept of Health WTC Registry Scientific Advisory Board, the NYS Governor's WTC panel and the NYC Mayor's medical advisory board.</p>

<p>Dr. Prezant has written extensively on pulmonary physiology, firefighter health and safety and since 9/11 on the health impact of World Trade Center Collapse on NYC Firefighters and EMS rescue workers. His group was the first to describe WTC Cough Syndrome (New England Journal of Medicine 2002) and has published extensively on this subject in the CDC MMWR, American Journal of Respiratory and Critical Care Medicine, Chest and Environmental Health Perspectives.</p>

<p>His major research interest is in determining the mechanisms responsible for accelerated decline in longitudinal pulmonary function and/or airway hyperreactivity in firefighters after WTC exposure. Other interests are in determining the mechanisms responsible for the increased incidence of sarcoidosis in firefighters after WTC exposure.</p>

<p><strong>Clinical Specialty Areas</strong></p>

<ul>
<li>environmental and occupational lung disease</li>

<li>firefighters respiratory disease</li>

<li>disaster medicine</li>

<li>pulmonary embolism</li>

<li>general pulmonary medicine</li>
</ul>

<p><strong>More</strong></p>

<p><a href="/medicine/pulmonarymedicine/pulmonary_about.aspx?id=14538">Seven Years Later, a Cough and a Covenant</a> (September 10, 2008)</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

Selected Publications

<ol>
<li>World Trade Center site. N Eng J Med 2002;347:806-15.</li>

<li>Banauch GI, McLaughlin M, Hirschhorn R, Corrigan M, Kelly KJ, Prezant DJ. Injuries and Illnesses among New York City Fire Department rescue workers after responding to the World Trade Center Attacks. MMWR 2002;51:1-5.</li>

<li>Prezant DJ, Kelly KJ, Jackson B, Peterson D, Feldman D, Baron S, Mueller CA, Bernard B, Lushniak B, Smith L, BerryAnn R, Hoffman B. Use of respiratory protection among responders at the World Trade Center Site, New York City, September 2001. MMWR 2002;51:6-8.</li>

<li>Rom WN, Weiden M, Garcia R, Ting AY, Vathesatogkit P, Tse DB, McGuinness G, Roggli V, Prezant DJ. Acute eosinophilic pneumonia in a New York City firefighter exposed to world trade center dust. Am. J. Resp. Crit. Care Med. 2002;166:797-800.</li>

<li>Banauch GI, Alleyne D, Sanchez R, Olender K, Weiden M, Kelly KJ, and PREZANT DJ. Persistent bronchial hyperreactivity in New York City firefighters and rescue workers following collapse of World Trade Center. Am. J. Resp. Crit. Care Med. 2003; 168:54-62.</li>

<li>Edelman P, Osterloh J, Pirkle J, Grainger J, Jones R, Blount B, Calafat A, Turner W, Caudill S, Feldman DM, Baron S, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Biomonitoring of chemical exposure among New York City firefighters responding to the World Trade Center fire and collapse. Environ Health Perspect, 2003; 111:1906-1911.</li>

<li>Feldman DM, Baron S, Mueller CA, Bernard BP, Lushniak BD, Kelly KJ, PREZANT DJ. Initial symptoms, respiratory function and respirator use in New York City firefighters responding to the World Trade Center (WTC) disaster. Chest 2004;125:1256-64.</li>

<li>World Trade Center dust. Environ Health Perspect, 2004; 112:1564-1569.</li>

<li>Banauch GI, Dhala A, Alleyne D, Alva R, Santhyadka G, Krasko A, Weiden M, Kelly KJ, Prezant DJ. Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med. 2005;33:S102-S106.</li>

<li>World Trade Center site. Curr Opin Pulm Med 2005; 11:160-8.</li>

<li>Paul Greene, Dianne Kane, Grace Christ, Sallie Lynch and Malachy Corrigan. FDNY crisis counseling: innovative responses to 9/11 firefighters, families, and communities. Published 2005.A textbook in counseling at FDNY after WTC.</li>

<li>Bars MP, Banauch GI, Appel DW, Andreaci M, Mouren P, Kelly KJ, Prezant DJ. Tobacco Free with FDNY: The New York City Fire Department World Trade Center Tobacco Cessation Study. Chest 2006; 129:979-987.</li>

<li>World Trade Center exposure in the New York City Fire Department. Am. J. Respir. Crit. Care Med. 2006; 174:312-319.</li>

<li>Friedman S, Cone J, Eros-Sarnyai M, Prezant D,m Szeinuk J, Clark N, Milek D, Levin S, Gillio R. Clinical guidelines for adults exposed to World Trade Center Disaster (Respiratory and Mental Health). City Health Info (CHI), NYC Department of Health and Mental Hygiene. September 2006</li>

<li>Lioy PJ, Pellizzari E, and Prezant DJ. Understanding and learning from the WTC Aftermath and its affect on health through Human Exposure Science. Environ. Science Technology. November 15, 2006 ; 6876-6885.</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Aldrich TK and Prezant DJ. World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers. CHEST (In press)</li>

<li>Izbicki G, Chavko R, Banauch GI, Weiden M, Berger K, Kelly KJ, Hall C, Aldrich TK and Prezant DJ.&#160; World Trade Center Sarcoid-like Granulomatous Pulmonary Disease in New York City Fire Department Rescue Workers.&#160; Chest, 2007;131:1414-1423</li>

<li>Weiden M, Banauch G, Kelly KJ, and Prezant DJ. Environmental and Occupational Medicine. Firefighters Health and Health Effects of the World Trade Center Collapse. Pgs 477-490. 4th Edition, Edited by Rom WN and Markowitz S. Lippincott-Raven Inc. Philadelphia, 2007.</li>

<li>Alvarez J, Rosen C, Davis K, Smith G, Corrigan M. Stay Connected : psychological services for retired firefighters after 11 September 2001.&#160; PreHospital Disaster Med. 2007 ;22 :49-54.</li>

<li>Menendez AM, Molloy J., Magaldi MC. Health responses of New York City firefighter spouses and their families post-September 11, 2001 terrorist attacks.&#160; Issues Ment Health Nurs. 2006; 27:905-17.</li>

<li>Kelly KJ, Niles J, McLaughlin MT, Carrol S, Corrigan M, Al-Othman F, and Prezant DJ.&#160; World Trade Center health Impacts on FDNY Rescue Workers - a six year assessment, September 2001 to 2007.&#160; Fire Department of the City of New York, October 2007. Available on-line at: <a href="http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…; target="_blank">http://www.nyc.gov/html/om/pdf/2007/wtc_health_impacts_on_fdny_rescue_w…;

<li>Prezant DJ. WTC Cough Syndrome and its Treatment. Lung. 2008 ; 186 :94S-102S.</li>

<li>Banauch GI, Izbicki G, Chavko R, Christodoulou V, Weiden MD, Webber MP, Cohen HW, Gustave J, Aldrich TK, Kelly KJ, and Prezant DJ. Trial of Prophylactic Inhaled Steroids to Prevent or Reduce Pulmonary Function Decline, Pulmonary Symptoms and Airway Hyperreactivity in Firefighters at the World Trade Center Site. Disaster Medicine and Public Health Preparedness 2008; 2:33-39.</li>

<li>Prezant DJ, Levin S, Kelly KJ, Aldrich TK.&#160; Upper and Lower Respiratory Diseases after Occupational and Environmental Disasters.&#160; Mt. Sinai Medical Journal (In Press).&#160;&#160;&#160;&#160;&#160;</li>
</ol>

<p>&#160;</p>

EMR ID

3430

Is Open Scheduling

Off

Kenneth L. Pinsker

https://assets.montefioreeinstein.org/profiles/images/physphoto/Pinsker_Kenneth_MD_420x504.jpg

First Name

Kenneth

Last Name

Pinsker

NPI

1306936273

Faculty ID

3368

CMO Specialties

Clinical Terms

Employment Status

Per Diem

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Kenneth Pinsker is Professor Emeritus of Medicine at Einstein and an attending physician at Montefiore. He is the former Chief of the Pulmonary Service at the Moses Division and the former Director of the Pulmonary Intensive Care Unit. He is currently a preceptor in the Pulmonary Clinic and makes teaching rounds on the consultation service.</p>
<p><strong>Clinical Specialty Areas</strong></p>
<ul>
<li>pulmonary function</li>
<li>bronchoscopy</li>
<li>pleural disease</li>
<li>general pulmonary medicine</li>
</ul>
<p><strong>Academic and Research Interests </strong></p>
<ul>
<li>lung transplantation</li>
<li>tuberculosis</li>
<li>respiratory failure</li>
<li>World-Trade-Center-related pulmonary disease</li>
<li>history of pulmonary medicine</li>
</ul>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3427

Is Open Scheduling

Off

Sami A. Nachman

https://assets.montefioreeinstein.org/profiles/images/physphoto/Nachman_Sami_MD_420x504.jpg

First Name

Sami

Last Name

Nachman

NPI

1255491932

Faculty ID

13896

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5711

Visit Type ID

2542

Is Open Scheduling

On

Zocdoc Link

Kerry A. Morrone

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/66099180-ee0e-11ee-a60f-4f2b57adc1a2.jpg

First Name

Kerry

Last Name

Morrone

NPI

1265734297

Faculty ID

12909

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Anemia, hospitalist medicine, general pediatrics</p>

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.

Research Focus

Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research

Elsevier Profile

EMR ID

4700

Biography

<p>Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.</p><p>Dr. Morrone graduated from New York University, earning her Bachelor of Arts in Biology in 2003. She then attended the Albert Einstein College of Medicine, where she received her Doctor of Medicine in 2007 and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Morrone completed her pediatric residency, chief residency, and pediatric hematology oncology fellowship all at the Albert Einstein College of Medicine. She has also been recognized for her teaching efforts many times and won the Leo M. Davidoff Society &ndash; Albert Einstein College of Medicine Teaching Award in 2010 and 2015.</p><p>Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research. Other current research interests include pulmonary complications of sickle cell disease particularly asthma and acute chest syndrome, in addition to infectious complications and thrombotic complications of sickle cell disease.</p>

Is Open Scheduling

Off

William B. Mitchell

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/7b27d4f0-0913-11ed-ba78-fb7207099d29.jpg

First Name

William

Last Name

Mitchell

NPI

1376512533

Faculty ID

16230

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

6188

Biography

<p>William Beau Mitchell, MD, is Director, Hemostasis and Thrombosis at the Children&rsquo;s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Mitchell&rsquo;s clinical focus centers on pediatric hematology, particularly bleeding and clotting disorders, with a special interest and expertise in platelet disorders.</p><p>After earning his Doctor of Medicine at Tufts University School of Medicine in 1994, Dr. Mitchell completed a pediatric internship at Boston Medical Center in 1995, followed by his pediatric residency at the same institution in 1997. He then completed a fellowship in pediatric hematology oncology at Mount Sinai School of Medicine in 2001 and a research fellowship in the laboratory of blood and vascular biology at Rockefeller University in 2006.</p><p>Dr. Mitchell&rsquo;s clinical research interests include novel therapies for rare blood disorders, hematological manifestations of disease, and transition from pediatric to adult care for patients with rare blood disorders. His basic science research interests include mechanisms of action of novel immune thrombocytopenia (ITP) therapies, platelet function in sickle cell disease, and the production of platelets from stem cells. Dr. Mitchell has been principal investigator and site principal investigator on a number of research projects, and he has given several national and international presentations. His work has been published in numerous peer-reviewed publications, books, chapters, and monographs, and he is an Associate Editor for Nature Pediatric Research. He is also a reviewer for many scientific journals, including the <em>Journal of Pediatrics: X</em>, <em>Pediatric Blood and Cancer</em> and the <em>Journal of Thrombosis and Haemostasis</em>.</p><p>Dr. Mitchell is board certified by the American Board of Pediatrics in Pediatrics and Pediatric Hematology Oncology. He is a member of the American Society of Hematology (ASH), the International Society for Hemostasis and Thrombosis (ISTH), and the American Society for Pediatric Hematology and Oncology (ASPHO). Dr. Mitchell has received two U.S. patents for his work in &ldquo;Regulation of Integrin Surface Expression&rdquo; and &ldquo;Megakaryocyte and Platelet Production from Stem Cells.&rdquo;</p>

Is Open Scheduling

Off